SD
Sudhindra Damodhar Rao
About Sudhindra Damodhar Rao
Sudhindra Damodhar Rao has 20 years in corporate governance. Holds Director and Managing Director roles. Currently with 2 companies, including Rajdisle Private Limited and Marig Ld Pharma Private Limited. Formerly with 2 companies, such as Jagdale Industries Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Rajdisle Private Limited
U21020KA2009PTC051674
|
Director | 30 Aug 2017 | 2009 | Active |
Marig Ld Pharma Private Limited
U74999KA2018PTC110123
|
Director | 13 Feb 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Jagdale Industries Private Limited
U33114KA1994PTC015825
|
Director | 18 Aug 2006 | 1994 | Active |
Rajdisle Private Limited
U93090KA2017PTC102861
|
Managing Director | 10 May 2017 | 2017 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudhindra Damodhar Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudhindra Damodhar Rao
Sudhindra Damodhar Rao has 20 years in corporate governance. Holds Director and Managing Director roles. Currently with 2 companies, including Rajdisle Private Limited and Marig Ld Pharma Private Limited. Formerly with 2 companies, such as Jagdale Industries Private Limited. Engaged in General Business. Contributes to corporate operations.
Sudhindra Damodhar Rao is associated with 2 companies as Director and Managing Director.
Sudhindra Damodhar Rao has expertise in General Business.
Sudhindra Damodhar Rao has 20 years in corporate governance.